subscribe iconSUBSCRIBE
Sign up for our publications
eMS News is the monthly email newsletter distributed from the Rocky Mountain MS Center. Each issue contains articles and features on the latest developments at the Rocky Mountain MS Center and general MS news from around the world. Regular features include the latest information on current clinical trials and research studies, upcoming events, fundraising activities and more. eMS News has been continuously published since March of 2009. 

Browse below for a selection of articles from eMS News. 

List of articles in category eMS News
Title Created Date
New Study Results Show Ocrelizumab Reduces Progression of Disability in Primary Progressive MS Patients 09.30.2015
Meet Your New Advanced Practitioners 09.23.2015
Rocky Mountain MS Center at University of Colorado: Blazing New Trails in MS Research 08.28.2015
The IMPRESS (International Multiple Sclerosis) Study 08.20.2015
New Study Shows Natalizumab (Tysabri) Significantly Improves Cognitive Impairment Over Three Years in MS Patients 07.30.2015
Possible New Link Between Brain and Immune System – Potential Implications for Understanding MS 06.29.2015
MS and Exercise Study – Encouraging Preliminary Results 06.29.2015
Highlights from the American Academy of Neurology Conference 05.22.2015
KADEP’s Exercise Program – An Interview with Kendra Greeney, Exercise Specialist 04.22.2015
Bacteria, Our Immune Systems, and MS 04.22.2015
Rocky Mountain MS Center Celebrates MS Awareness Month in March 03.02.2015
RMMSC Annual Gala Welcomes Dr. Patch Adams 02.17.2015
MS 101 02.16.2015
Recent Stem Cell Research Study: Positive Results, But Includes Significant Limitations 02.16.2015
MS and Exercise Study: An Interview with Dr. Roger Enoka 01.28.2015
KADEP Celebrates 24th Birthday! 01.15.2015
Questions and Answers from Education Summit - Part 2 01.14.2015
MS Vaccine Project Moves into Next Stage of Research 12.10.2014
MS and Stress: Recalibrating for the Holidays 12.10.2014
Alemtuzumab (Lemtrada) Approved by FDA 11.25.2014

  

Share This Page: